Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting

Scott J. Leischow; James Ranger-Moore; Myra L. Muramoto; Eva Matthews

doi:10.5993/AJHB.28.4.1

Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting

Scott J. Leischow, James Ranger-Moore, Myra L. Muramoto, Eva Matthews

Family and Community Medicine

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Objective: To evaluate the effectiveness of the Nicotrol® nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. Results: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was .77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. Conclusions: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.

Original language	English (US)
Pages (from-to)	291-301
Number of pages	11
Journal	American journal of health behavior
Volume	28
Issue number	4
DOIs	https://doi.org/10.5993/AJHB.28.4.1
State	Published - 2004

Keywords

Nicotine inhaler
OTC
Smoking cessation
nicotine replacement.

ASJC Scopus subject areas

Health(social science)
Social Psychology
Public Health, Environmental and Occupational Health

Access to Document

10.5993/AJHB.28.4.1

Cite this

@article{18cbcec6a2954a55a1445c08fd27f3f1,

title = "Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting",

abstract = "Objective: To evaluate the effectiveness of the Nicotrol{\textregistered} nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. Results: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was .77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. Conclusions: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.",

keywords = "Nicotine inhaler, OTC, Smoking cessation, nicotine replacement.",

author = "Leischow, {Scott J.} and James Ranger-Moore and Muramoto, {Myra L.} and Eva Matthews",

year = "2004",

doi = "10.5993/AJHB.28.4.1",

language = "English (US)",

volume = "28",

pages = "291--301",

journal = "American journal of health behavior",

issn = "1087-3244",

publisher = "PNG Publications",

number = "4",

}

TY - JOUR

T1 - Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting

AU - Leischow, Scott J.

AU - Ranger-Moore, James

AU - Muramoto, Myra L.

AU - Matthews, Eva

PY - 2004

Y1 - 2004

N2 - Objective: To evaluate the effectiveness of the Nicotrol® nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. Results: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was .77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. Conclusions: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.

AB - Objective: To evaluate the effectiveness of the Nicotrol® nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. Results: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was .77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. Conclusions: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.

KW - Nicotine inhaler

KW - OTC

KW - Smoking cessation

KW - nicotine replacement.

UR - http://www.scopus.com/inward/record.url?scp=4444277672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444277672&partnerID=8YFLogxK

U2 - 10.5993/AJHB.28.4.1

DO - 10.5993/AJHB.28.4.1

M3 - Article

C2 - 15228966

AN - SCOPUS:4444277672

SN - 1087-3244

VL - 28

SP - 291

EP - 301

JO - American journal of health behavior

JF - American journal of health behavior

IS - 4

ER -

Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this